SEPT11 targets RhoA in vitro, regulates cytoskeleton rearrangement and abnormal cell adhesion through ROCK1 and FAK signaling pathways, thereby promoting the invasion and migration of HCC. Here, RHOA is linked to hepatocellular carcinoma.